Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis-Reference-Cited by-同舟云学术

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis

Published:2009-03-15 Issue:3 Volume:61 Page:291-299
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Van den Hout Wilbert B.,Goekoop-Ruiterman Yvonne P. M.,Allaart Cornelia F.,De Vries-Bouwstra Jeska K.,M. Hazes J. Mieke,Kerstens Pit J. S. M.,Van Zeben Derkjen,Hulsmans Harry M. J.,De Jonge-Bok Johanna M.,De Sonnaville Peter B. J.,Dijkmans Ben A. C.,Breedveld Ferdinand C.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.24169/fullpdf

Reference48 articles.

1. Early rheumatoid arthritis: pitfalls in diagnosis and review of recent clinical trials;Cannella;Drugs,2006

2. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis;Boers;Lancet,1997

3. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate;Weinblatt;N Engl J Med,1999

4. Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial;Gerards;Ann Rheum Dis,2003

5. Infliximab in active early rheumatoid arthritis;Breedveld;Ann Rheum Dis,2004

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial;RMD Open;2024-08

2. Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?;Annals of the Rheumatic Diseases;2023-08-22

3. Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial;Seminars in Arthritis and Rheumatism;2022-12

4. Estimating Productivity Loss from Breast and Non–Small-Cell Lung Cancer among Working-Age Patients and Unpaid Caregivers: A Survey Study Using the Multiplier Method;MDM Policy & Practice;2022-07

5. Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis;Annals of the Rheumatic Diseases;2022-04-25